360° Coverage : Asthma drug that cures severe itchy rash

3 Updates
Asthma drug that cures severe itchy rash
Photo Credit: Spencer Platt, Getty Images

Asthma drug that cures severe itchy rash

Feb 24 2013, 10:08pm CST | by

Washington, Feb 25 (IANS) A high-dose shot of a common asthma drug, once a month, has been found to be highly effective in treating teens and adults chronically afflicted with severe, itchy rash, says a new study.

Washington, Feb 25 — A high-dose shot of a common asthma drug, once a month, has been found to be highly effective in treating teens and adults chronically afflicted with severe, itchy rash, says a...

Filed under: news

YouTube Videos

 
 
 

1 year ago

Asthma drug that cures severe itchy rash

Feb 24 2013, 10:08pm CST | by

Washington, Feb 25 (IANS) A high-dose shot of a common asthma drug, once a month, has been found to be highly effective in treating teens and adults chronically afflicted with severe, itchy rash, says a new study.

Washington, Feb 25 — A high-dose shot of a common asthma drug, once a month, has been found to be highly effective in treating teens and adults chronically afflicted with severe, itchy rash, says a new study.

Known as omalizumab, the drug was tested on 323 people at 55 medical centres for whom standard antihistamine therapy failed to quell underlying, allergy-like reaction, known as chronic idiopathic urticaria or chronic spontaneous urticaria.

"Physicians and patients may now have a fast, safe and well-tolerated treatment option to consider before prescribing even more antihistamines, which can be highly sedating," says Sarbjit (Romi) Saini, Johns Hopkins allergist and immunologist, and study co-investigator, the The New England Journal of Medicine reports.

The study, from 2009 to 2011, involved mostly women aged between 12 and 75 years. Each was randomly assigned to take one of three dosing regimens of omalizumab, or placebo, after which they were monitored through regular checkups for four months, according to a Johns Hopkins statement.

All of them had chronic hives (itchy bumps on the skin) and rash for at least six months, with many having suffered from the condition for more than five years.

"Patients suffering with this condition need more and better treatment options because chronic hives and rash are profoundly hard to treat and can be very debilitating," says Saini, associate professor at the Johns Hopkins University School of Medicine.

Saini, who has studied omalizumab since 2005, points out that fewer than half of those treated respond to traditional drug treatments with antihistamines. Saini says the new study results offer substantial evidence that this first injection treatment option not only works, but does so more safely than other drugs.

These findings were presented at the annual meeting of the American Academy of Allergy, Asthma and Immunology in San Antonio, Texas.

IANS

Source: IANS

 
Update
3

2 weeks ago

Cipla launches copy of GSK's top asthma drug in Germany, Sweden

Sep 1 2014 8:03am CDT | Source: Business Standard

Cipla's drug will be marketed under the name Serrofloin in Germany and Salmeterol/Fluticasone Cipl ...
Source: Business Standard   Full article at: Business Standard
 

 
Update
2

7 weeks ago

Boon for Asthma Patients: Vaccine for Dust Mite Allergies Developed

Jul 23 2014 6:02am CDT | Source: IBTimes UK

A vaccine against dust mite allergies has been develop ...
Source: IBTimes UK   Full article at: IBTimes UK
 

 

Don't miss ...

 

<a href="/latest_stories/all/all/8" rel="author">Luigi Lugmayr</a>
Luigi is the founding Chief Editor of I4U News and brings over 15 years experience in the technology field to the ever evolving and exciting world of gadgets. He started I4U News back in 2000 and evolved it into vibrant technology magazine.
Luigi can be contacted directly at ml@i4u.com. Luigi posts regularly on LuigiMe.com about his experience running I4U.

 

blog comments powered by Disqus

Latest stories

Why marijuana users end up feeling worse
New York, Sep 15 (IANS) Adolescents and young adults who smoke marijuana frequently may attempt to manage negative moods by using the drug but end up feeling worse, says a new study.
 
 
Schizophrenia a group of eight distinct disorders: Study
Washington, Sep 15 (IANS) The debilitating psychiatric illness schizophrenia is not a single disease but a group of eight genetically distinct disorders - each with its own set of symptoms, new research indicates.
 
 
'Old climate change formula no longer exists'
Washington, Sep 15 (IANS) The traditional formula on climate change that says that regions that have a moist climate will experience additional rainfall is no longer valid, scientists say.
 
 
OPEC daily basket price closes higher
Vienna, Sep 15 (IANS/WAM) The basket of 12 crude oils of the Organisation of Petroleum Exporting Countries (OPEC) closed at $95.68 a barrel Friday, compared to $95.35 a barrel last Thursday, the OPEC Secretariat said.
 
 
 

Latest from the Network

New Zealand PM declassifies spy documents
Wellington, Sep 15 (IANS) New Zealand Prime Minister John Key Monday released previously classified documents regarding the country's security agencies as his government became the latest target of claims by US spy...
Read more on Politics Balla
 
Libyan PM rejects talks with armed Islamist group
Tripoli, Sep 15 (IANS) Libyan Prime Minister Abdullah al-Thinni has ruled out any negotiations with the Libya Dawn Islamist armed alliance, saying the government will launch new assaults to wipe it out. Sky News...
Read more on Politics Balla
 
Toll in Philippines ferry capsize rises to six
Manila, Sep 15 (IANS) The toll from the sinking of a ship off Panaoan island in the central Philippine province of Southern Leyte has climbed to six, the Philippine Navy said Monday. Marineth Domingo, spokesman of the...
Read more on Politics Balla
 
Why marijuana users end up feeling worse
New York, Sep 15 (IANS) Adolescents and young adults who smoke marijuana frequently may attempt to manage negative moods by using the drug but end up feeling worse, says a new study. "Marijuana use is a vicious circle...
Read more on Celebrity Balla
 
App to track what makes you truly happy
Washington, Sep 15 (IANS) Do you think the smartphone is a source of undue stress? Try this app created by three students at the University of California-Berkeley that claims to make them a source of goodness. The "...
Read more on Celebrity Balla
 
Schizophrenia a group of eight distinct disorders: Study
Washington, Sep 15 (IANS) The debilitating psychiatric illness schizophrenia is not a single disease but a group of eight genetically distinct disorders - each with its own set of symptoms, new research indicates. In...
Read more on Apple Balla
 
Hillary Clinton visits Iowa, a key election state
Washington, Sep 15 (IANS/EFE) Former US secretary of state Hillary Clinton has taken part in a fundraising event in Iowa, a key state in the upcoming presidential campaign, triggering fresh speculation about her...
Read more on Politics Balla
 
Egypt court releases prominent activist on bail
Cairo, Sep 15 (IANS) An Egyptian court Monday ordered the release on bail of leading activist Alaa Abdel Fattah, who is held on charges of protesting without police permit, and referred the case to another court, media...
Read more on Politics Balla
 
'Old climate change formula no longer exists'
Washington, Sep 15 (IANS) The traditional formula on climate change that says that regions that have a moist climate will experience additional rainfall is no longer valid, scientists say. The old formula that dry...
Read more on Apple Balla
 
One Direction's new single due late September
London, Sep 15 (IANS) One Direction's next single titled "Steal my girl" from their upcoming album "FOUR" will release Sep 29. The band's Liam Payne shared the news on Twitter, reports billboard.com. A photo of the...
Read more on Celebrity Balla